nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A maintained absolute lymphocyte count predicts the overall survival benefit from eribulin therapy, including eribulin re-administration, in HER2-negative advanced breast cancer patients: a single-institutional experience
|
Watanabe, J. |
|
|
181 |
1 |
p. 211-220 |
artikel |
2 |
Behavior of metastatic breast cancer according to subtype
|
Van Mechelen, Margot |
|
|
181 |
1 |
p. 115-125 |
artikel |
3 |
Breast implant-associated anaplastic large cell lymphoma: emotional impact and guidelines for psychological support
|
Oliveri, Serena |
|
|
181 |
1 |
p. 221-224 |
artikel |
4 |
Comparison of outcomes in a population-based cohort of metastatic breast cancer patients receiving anti-HER2 therapy with clinical trial outcomes
|
Gong, Inna Y. |
|
|
181 |
1 |
p. 155-165 |
artikel |
5 |
Computed tomography-based analyses of baseline body composition parameters and changes in breast cancer patients under treatment with CDK 4/6 inhibitors
|
Franzoi, Maria Alice |
|
|
181 |
1 |
p. 199-209 |
artikel |
6 |
Frequency of radiation-induced malignancies post-adjuvant radiotherapy for breast cancer in patients with Li-Fraumeni syndrome
|
Le, Anh N. |
|
|
181 |
1 |
p. 181-188 |
artikel |
7 |
HER2 borderline is a negative prognostic factor for primary malignant breast cancer
|
Bhattacharjee, Atanu |
|
|
181 |
1 |
p. 225-231 |
artikel |
8 |
Insulin-like growth factor-1 receptor (IGF-1R) expression on circulating tumor cells (CTCs) and metastatic breast cancer outcome: results from the TransMYME trial
|
Gennari, Alessandra |
|
|
181 |
1 |
p. 61-68 |
artikel |
9 |
LLY17, a novel small molecule STAT3 inhibitor induces apoptosis and suppresses cell migration and tumor growth in triple-negative breast cancer
|
Pan, Li |
|
|
181 |
1 |
p. 31-41 |
artikel |
10 |
Long-term (up to 16 months) health-related quality of life after adjuvant tailored dose-dense chemotherapy vs. standard three-weekly chemotherapy in women with high-risk early breast cancer
|
Brandberg, Yvonne |
|
|
181 |
1 |
p. 87-96 |
artikel |
11 |
Meta-analyses on progression-free survival as a surrogate endpoint for overall survival in triple-negative breast cancer
|
Hirai, Takehiro |
|
|
181 |
1 |
p. 189-198 |
artikel |
12 |
Metformin is distributed to tumor tissue in breast cancer patients in vivo: A 11C-metformin PET/CT study
|
Sundelin, Elias Immanuel Ordell |
|
|
181 |
1 |
p. 107-113 |
artikel |
13 |
Mitotic score and pleomorphic histology in invasive lobular carcinoma of the breast: impact on disease-free survival
|
Mukhtar, Rita A. |
|
|
181 |
1 |
p. 23-29 |
artikel |
14 |
Neoadjuvant treatment strategies for HER2-positive breast cancer: cost-effectiveness and quality of life outcomes
|
Hassett, M. J. |
|
|
181 |
1 |
p. 43-51 |
artikel |
15 |
Obesity-associated methylation in breast tumors: a possible link to disparate outcomes?
|
Do, Whitney L. |
|
|
181 |
1 |
p. 135-144 |
artikel |
16 |
Peritumoral edema as a biomarker of the aggressiveness of breast cancer: results of a retrospective study on a 3 T scanner
|
Panzironi, Giovanna |
|
|
181 |
1 |
p. 53-60 |
artikel |
17 |
Preserving fertility in young women undergoing chemotherapy for early breast cancer; the Maastricht experience
|
Vriens, Ingeborg J. H. |
|
|
181 |
1 |
p. 77-86 |
artikel |
18 |
Racial differences in estrogen receptor staining levels and implications for treatment and survival among estrogen receptor positive, HER2-negative invasive breast cancers
|
Purrington, Kristen S. |
|
|
181 |
1 |
p. 145-154 |
artikel |
19 |
Risk-reducing mastectomy: a case series of 124 procedures in Brazilian patients
|
Frasson, Antônio Luiz |
|
|
181 |
1 |
p. 69-75 |
artikel |
20 |
Safety and tolerability of subcutaneous trastuzumab at home administration, results of the phase IIIb open-label BELIS study in HER2-positive early breast cancer
|
Denys, Hannelore |
|
|
181 |
1 |
p. 97-105 |
artikel |
21 |
The association between soy isoflavone intake and menopausal symptoms after breast cancer diagnosis: a prospective longitudinal cohort study on Chinese breast cancer patients
|
Lei, Yuan-Yuan |
|
|
181 |
1 |
p. 167-180 |
artikel |
22 |
The Mitotic Activity Index in combination with Her2neu: a strong prognosticator in breast cancer
|
Jobsen, Jan J. |
|
|
181 |
1 |
p. 13-21 |
artikel |
23 |
The solute carrier SLC7A8 is a marker of favourable prognosis in ER-positive low proliferative invasive breast cancer
|
El Ansari, Rokaya |
|
|
181 |
1 |
p. 1-12 |
artikel |
24 |
Ultrasound characteristics of sclerosing adenosis mimicking breast carcinoma
|
Liu, Wei |
|
|
181 |
1 |
p. 127-134 |
artikel |